Taken together these results suggest that prostate cancer metastases more frequently harbour genetic changes associated with over-expression of drebrin, and proteins regulating drebrin’s actin bundling activity, as compared with primary prostate cancer samples, raising the possibility that these events might promote (or at least be associated with) prostate cancer progression to a metastatic phenotype. This evidence concerns the gene DBN1 and prostate cancer.